Helmut H. Albrecht, MD, MS, FFPM
Chief Scientific Officer



Dr. Helmut H. Albrecht is Chief Scientific Officer at Alitair. He is a 25+ year veteran of the pharmaceutical business and brings a wealth of product development experience to Alitair.  Most recently, Helmut was head of R&D at Adams Respiratory Therapeutics (Adams) where he managed a wide variety of product innovation as well as clinical and other development projects for various respiratory conditions (esp. in cough, COPD and allergy). He was also a member of the senior management team at Adams.

Prior to joining Adams, Helmut was VP of global Preclinical and Clinical Development and Drug Safety for the Novartis Consumer Health (NCH) OTC business unit and before the globalization of the NCH R&D organization, he served as VP for R&D OTC, North America with responsibility for all R&D functions in the NCH OTC business unit in NA. Earlier in his career he held key positions in the area of pharmaceutical medicine, involving Rx and OTC drugs as well as dietary supplements at SmithKline Beecham Consumer Health, Procter & Gamble OTC Health Care and P&G Pharmaceuticals, and Altana Pharmaceuticals.

Helmut has a doctor of medicine from the University of Heidelberg as well as a Master of Science degree in Management & Policy and an advanced New York State Certificate in Health Care Management from SUNY at Stony Brook.  He has a diploma in pharmaceutical medicine and is a fellow, as well as previous board member, of the Faculty of Pharmaceutical Medicine (FFPM).